Novel Enzyme-Based Immunoassay for Simultaneous Detection of Hepatitis C Virus Antigen and Antibody in Human Serum or Plasma
This technology overcomes these challenges through simultaneous detection of both HCV core antigen and HCV antibody in an immunoassay format, which both significantly improves the sensitive diagnosis of hepatitis C among blood donors at any stage of infection and is also simpler to perform than combination testing utilizing PCR-based techniques.
- Monitoring and early, accurate diagnosis of hepatitis C virus (HCV) infected individuals
- Rapid screening tool for blood donations and high-risk individuals
- Lateral-flow assays, HCV detection kits
- Efficiently overcomes the window of potential false-negative diagnosis between time of inital hepatitis C infection and patient seroconversion by implementation of an accurate, sensitive immunoassay
- Assay significantly improves diagnosis beyond stand-alone HCV core antigen or antibody measures
- Detects the presence of HCV both prior to and following seroconversion without reliance on PCR-based techniques